DALLAS – Enhabit, Inc. (NYSE: EHAB), a prominent home health and hospice provider, concluded its strategic review process and decided to maintain its status as an independent, public company. The review, initiated in August 2023, was led by the Board of Directors with Goldman Sachs and Sidley Austin serving as financial and legal advisors, respectively.
The strategic review involved exploring a range of options, including a potential sale, merger, or other transaction. Despite receiving indications of interest and executing Non-Disclosure Agreements with several parties, no formal proposals for a transaction were presented. The Board cited macroeconomic challenges, such as uncertain regulatory developments, difficult healthcare operating conditions, and high interest rates, as factors that hindered any deal that could have benefitted shareholders.
Leo Higdon, Chairperson of the Board, stated that after considering various strategic alternatives and the current market environment, they believe operating independently is the best course to enhance shareholder value. The Board plans to continue evaluating all opportunities to achieve this goal.
Barbara Jacobsmeyer, President and CEO, expressed confidence in the company’s direction, highlighting the positive momentum from 2023 into the first quarter of 2024. The company’s focus has been on hiring frontline clinicians, securing favorable home health payer contracts, and controlling general and administrative expenses.
The Board also confirmed the previously disclosed transition plan, with four of the five legacy Encompass Health (NYSE:) Corporation directors not standing for re-election at the upcoming 2024 annual shareholder meeting. This will reduce the Board’s size to nine directors. The transition is part of a commitment to evolve the Board’s composition following the company’s separation from Encompass in July 2022.
remove ads
.
Enhabit operates across 34 states with 255 home health locations and 112 hospice locations. The company is known for using advanced technology and compassionate care teams to provide quality patient care in the home.
InvestingPro Insights
In the wake of Enhabit, Inc.’s decision to remain an independent entity, it’s important for investors to consider the company’s financial health and market position. According to InvestingPro data, Enhabit’s market capitalization stands at $496.54 million,…
Click Here to Read the Full Original Article at All News…
